Maria Pantelidou
Papers
1
Total Citations
62
H-Index
1
About
Dr. Maria Pantelidou is a leading urologic oncologist whose research focuses on optimizing treatment strategies for renal cell carcinoma (RCC), particularly through minimally invasive techniques. Her most cited work, a 2016 retrospective analysis comparing percutaneous radiofrequency ablation (RFA) with robotic-assisted partial nephrectomy (RPN) for small renal tumors, has garnered 62 citations and provides critical comparative data on oncologic outcomes for T1 stage RCC. This study, conducted at a high-volume tertiary centre, directly informs clinical decision-making for patients and surgeons weighing the benefits of thermal ablation versus robotic surgery. Beyond this landmark paper, Dr. Pantelidou’s broader contributions include advancing the evidence base for nephron-sparing approaches, refining patient selection criteria, and evaluating long-term survival outcomes. Her work has been instrumental in demonstrating that both RFA and RPN offer effective, minimally invasive options for small renal masses, helping to reduce overtreatment while preserving renal function. With a career dedicated to bridging surgical innovation and evidence-based practice, Dr. Pantelidou continues to shape the landscape of urologic oncology through rigorous clinical research and collaborative, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1